Physician profile
Sadia Waheed
NPI 1386104487
$5,567.20
in general payments reported to CMS, 2019-2025
16 companies · $791 in 2025
The $791 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.65 · 2020: $57.82 · 2021: $427 · 2022: $137 · 2023: $206 · 2024: $3,934 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,497 · Food and Beverage: $1,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,497.22 |
| Food and Beverage | $1,434.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,356.82 | 2024-2025 | Infinity |
| Alexion Pharmaceuticals, INC. | $242.93 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $235.44 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $140.28 | 2021 | |
| Medtronic, INC. | $122.52 | 2023-2024 | Solitaire X, Percept Pc Brainsense, Rist |
| Abbvie INC. | $120.10 | 2021-2023 | Botox, Ubrelvy |
| Biogen, INC. | $99.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $80.38 | 2025 | Austedo Xr |
| Genzyme Corporation | $37.96 | 2020-2021 | |
| Boston Scientific Corporation | $27.98 | 2024 | Vercise |
| Csl Behring | $23.94 | 2020 | |
| Lundbeck LLC | $18.69 | 2022 | |
| Celgene Corporation | $16.14 | 2021 | |
| Ucb, INC. | $15.52 | 2020 | |
| Avanir Pharmaceuticals, INC. | $14.65 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sadia Waheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.